Statistics from Altmetric.com
In their interesting paper, Smith et al1 postulate that after a negative test for BRCA1 and BRCA2, women are still at increased risk of cancer. They therefore recommend to continue screening.
I think there are several reasons why surveillance recommendations, after a negative test for the family mutation, are premature.
(1) It should be clear how high the rest risk is. This …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.